SEC Company Response from WINDTREE THERAPEUTICS (WINT) — Apr 12, 2017
WINDTREE THERAPEUTICS INC /DE/ (WINT, WINTW) (CIK 0000946486)
Date: April 12, 2017 · CIK: 0000946486 · Accession: 0001437749-17-006529
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-217161
Letter
wint20170412_corresp.htm
WINDTREE THERAPEUTICS, INC.
2600 Kelly Road, Suite 100
Warrington, Pennsylvania 18976
P - 215.488.9300
F - 215.488.9557
www.windtreetx.com
April 12, 2017
Suzanne Hayes
Assistant Director
Office of Healthcare and Insurance
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re: Windtree Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-217161
Acceleration Request
Requested Date: April 14, 2017
Requested Time: 5:00 PM Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Windtree Therapeutics, Inc. (the "Company"), a Delaware corporation, hereby requests that the effectiveness of the Company’s Registration Statement on Form S-1, File No. 333-217161, be accelerated to the date and time set forth above, or as soon thereafter as is practicable.
Very truly yours,
WINDTREE THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm wint20170412_corresp.htm WINDTREE THERAPEUTICS, INC. 2600 Kelly Road, Suite 100 Warrington, Pennsylvania 18976 P - 215.488.9300 F - 215.488.9557 www.windtreetx.com April 12, 2017 Suzanne Hayes Assistant Director Office of Healthcare and Insurance Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: Windtree Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-217161 Acceleration Request Requested Date: April 14, 2017 Requested Time: 5:00 PM Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Windtree Therapeutics, Inc. (the "Company"), a Delaware corporation, hereby requests that the effectiveness of the Company’s Registration Statement on Form S-1, File No. 333-217161, be accelerated to the date and time set forth above, or as soon thereafter as is practicable. Very truly yours, WINDTREE THERAPEUTICS, INC. /s/ Mary B. Templeton Mary B. Templeton Senior Vice President, General Counsel and Corporate Secretary cc: Ira L. Kotel, Dentons US LLP